Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in VSports app下载. gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

Review
. 2019 Jan 20;11(1):119.
doi: 10.3390/cancers11010119.

Platinum Resistance in Ovarian Cancer: Role of DNA Repair (VSports)

Giovanna Damia  1 , Massimo Broggini  2
Affiliations
Review

Platinum Resistance in Ovarian Cancer: Role of DNA Repair

Giovanna Damia et al. Cancers (Basel). .

Abstract

Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. It is initially responsive to cisplatin and carboplatin, two DNA damaging agents used in first line therapy. However, almost invariably, patients relapse with a tumor resistant to subsequent treatment with platinum containing drugs VSports手机版. Several mechanisms associated with the development of acquired drug resistance have been reported. Here we focused our attention on DNA repair mechanisms, which are fundamental for recognition and removal of platinum adducts and hence for the ability of these drugs to exert their activity. We analyzed the major DNA repair pathways potentially involved in drug resistance, detailing gene mutation, duplication or deletion as well as polymorphisms as potential biomarkers for drug resistance development. We dissected potential ways to overcome DNA repair-associated drug resistance thanks to the development of new combinations and/or drugs directly targeting DNA repair proteins or taking advantage of the vulnerability arising from DNA repair defects in EOCs. .

Keywords: DNA damage response; DNA damaging agents; DNA polymorphisms; DNA repair; cisplatin; drug resistance; gene mutations; homologous recombination; nucleotide excision repair; ovarian cancer V体育安卓版. .

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of the major pathways involved in DNA damage recognition and repair of platinum DNA damage. The major proteins acting as sensors and effectors of the DNA damage are reported. According to the tumor cell ability to repair the damage, cells will survive and acquired resistance to treatment or not repair and die.
See this image and copyright information in PMC

References

    1. Ishida: S., McCormick F., Smith-McCune K., Hanahan D. Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator. Cancer Cell. 2010;17:574–583. doi: 10.1016/j.ccr.2010.04.011. - V体育官网 - DOI - PMC - PubMed
    1. Li T., Peng J., Zeng F., Zhang K., Liu J., Li X., Ouyang Q., Wang G., Wang L., Liu Z., et al. Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer. Int. J. Clin. Pharm. 2017;55:774–780. doi: 10.5414/CP202907. - DOI - PubMed
    1. Kishimoto S., Yasuda M., Fukushima S. Changes in the Expression of Various Transporters as Influencing Factors of Resistance to Cisplatin. Anticancer Res. 2017;37:5477–5484. - V体育平台登录 - PubMed
    1. Öhrvik H., Nose Y., Wood L.K., Kim B.-E., Gleber S.-C., Ralle M., Thiele D.J. Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain. Proc. Natl. Acad. Sci. USA. 2013;110:E4279–E4288. doi: 10.1073/pnas.1311749110. - DOI - PMC - PubMed
    1. Sørensen B.H., Dam C.S., Stürup S., Lambert I.H. Dual role of LRRC8A-containing transporters on cisplatin resistance in human ovarian cancer cells. J. Inorg. Biochem. 2016;160:287–295. doi: 10.1016/j.jinorgbio.2016.04.004. - DOI - PubMed